YOLFTbeta
Tenon Medical Inc

Tenon Medical Inc

TNON · NASDAQ · Healthcare / Medical Devices

1.41USD-0.38 (-21.23%)

Price History

Full chart

Market Stats

Previous Close1.79
Open1.75
Day Range1.38 – 1.75
52-Week Range2.40 – 50.40
Volume184.22K
Market Cap2.09M
P/E (TTM)0.00
Forward P/E0.00
EPS-42.75
Dividend Yield0.00%
Beta1.36
50-Day Avg5.58
200-Day Avg21.46

About

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Steven M. Foster
  • Employees26
  • Headquarters104 Cooper Court, Los Gatos, CA, United States, 95032, USA
  • Websitehttps://www.tenonmed.com

Leadership

  • Mr. Richard M. FerrariFounder & Executive Chairman · b. 1954
  • Mr. Steven M. FosterCEO, President & Director · b. 1968
  • Mr. Richard GinnFounder, CTO, COO & Director · b. 1966
  • Mr. Kevin WilliamsonCFO & Secretary · b. 1986
  • Mr. Steve MoscaretGeneral Manager of Marketing & Sales Operation
  • Mr. Nathaniel A. GraweyChief Commercial Officer · b. 1983
  • Mr. Wyatt Drake GeistChief Innovation Officer

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue53.64K43.82K160.00K691.00K2.93M3.28M3.94M
Growth (%)--18.31%+265.13%+331.88%+323.73%+11.92%+20.35%
Cost of Revenue18.26K18.26K55.00K1.33M1.69M1.57M1.59M
Gross Profit35.38K25.56K105.00K-641.00K1.24M1.71M2.36M
Gross Margin65.96%58.34%65.63%-92.76%42.38%52.21%59.79%
Operating Expense568.82K561.85K6.57M18.08M16.97M15.48M15.15M
Operating Income-533.44K-536.29K-6.46M-18.73M-15.73M-13.77M-12.79M
Operating Margin-994.48%-1223.85%-4038.13%-2709.84%-537.12%-420.08%-324.34%
EBITDA-30-537.52K-6.35M-18.27M-15.13M-12.98M-12.03M
EBITDA Margin-0.06%-1226.65%-3966.25%-2644.57%-516.87%-396.22%-304.92%
Net Income-509.58K-585.18K-7.05M-18.92M-15.58M-13.67M-12.56M
Net Income Margin-950.00%-1335.41%-4405.00%-2737.63%-532.14%-417.24%-318.36%
R&D371.55K220.88K1.72M2.83M3.16M2.60M2.15M
R&D as % of Total Revenue692.66%504.07%1073.75%409.26%108.03%79.43%54.49%
Interest Expense52.36K167.85K621.00K354.00K21.00K34.00K0
Interest Expense % of Total Revenue97.61%383.04%388.13%51.23%0.72%1.04%0.00%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets268.45K390.90K9.27M11.09M6.34M9.84M10.76M
Total Liabilities1.88M1.83M29.82M4.84M5.57M3.87M5.72M
Total Equity-2.61M-3.14M-20.55M6.25M778.00K5.97M5.04M
Cash151.97K245.63K2.92M2.13M2.43M6.54M3.76M
Total Debt927.80K574.98K14.62M911.00K1.86M428.00K141.00K
Net Debt775.84K329.34K11.70M-1.22M-571.00K-6.11M-3.62M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-235.20K-167.36K-4.29M-12.03M-12.18M-9.88M-10.74M
Investing Cash Flow64.49K-4.50M-4.50M-2.88M6.14M-186.00K-1.02M
Financing Cash Flow321.31K254.80K11.47M14.11M6.30M14.13M8.99M
Capital Expenditure102.00K3102.00K847.00K361.00K186.00K273.00K
Free Cash Flow-235.20K-167.36K-4.39M-12.87M-12.54M-10.06M-11.02M
FCF to OCF100.00%100.00%102.38%107.04%102.96%101.88%102.54%

Earnings

Report DateAug 30, 2021Nov 10, 2021Jun 9, 2022Aug 10, 2022Nov 10, 2022Mar 8, 2023May 9, 2023Aug 7, 2023Nov 14, 2023Mar 12, 2024May 13, 2024Aug 13, 2024Nov 14, 2024Mar 10, 2025May 13, 2025Aug 13, 2025Nov 13, 2025Mar 19, 2026May 13, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate0.000.00--16.00-37.60-64.80-0.37-30.40-22.40-1.38-10.72-8.68-6.16-3.77-0.92-0.47-0.37-0.36-10.68-8.40-5.62
EPS Actual-0.17-0.02-0.25-39.07-22.40-56.00-0.43-26.40-11.68-0.68-10.00-1.02-3.63-0.98-1.01-0.36-0.40-0.22-10.85-12.35-
Surprise----144.19%40.43%13.58%-16.22%13.16%47.86%50.72%6.72%88.25%41.07%73.91%-9.78%23.40%-8.11%38.89%-1.64%-47.02%-
Timing--After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap2.09M
Enterprise Value9.26M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.39
Price / Book4.02
EPS-42.75
Book Value-14.57
Revenue (TTM)5.31M
Gross Profit (TTM)3.55M
EBITDA-11.80M
Profit Margin-257.85%
Operating Margin-262.24%
Return on Equity-551.19%
Return on Assets-71.98%
Shares Outstanding667.05K
Shares Float620.83K
Beta1.36
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 44.38
  • Strong Buy
    1
  • Buy
    1

Ownership Breakdown

Institutions
4.48%
Insiders
5.85%
Retail / Other
89.67%

Top Institutional Holders

  • Geode Capital Management, LLC
    167.49K1.45%
  • Vanguard Capital Management, LLC
    71.72K0.62%
  • Vanguard Fiduciary Trust Co
    44.63K0.39%
  • SBI Securities Co Ltd
    39.72K0.34%
  • Northern Trust Corp
    18.05K0.16%
  • Spectrum Asset Management Inc
    10.65K0.09%
  • Citigroup Inc
    9.86K0.09%
  • UBS Group AG
    4.18K0.04%
  • Tower Research Capital LLC
    9160.01%
  • Morgan Stanley - Brokerage Accounts
    1880.00%
  • BNP Paribas Arbitrage, SA
    240.00%
  • Hanson Mcclain Inc
    200.00%
  • DRW Securities, LLC
    00.00%
  • Citadel Advisors Llc
    00.00%
  • Virtu Financial LLC
    00.00%
  • XTX Topco Ltd
    00.00%
  • TWO SIGMA SECURITIES, LLC
    00.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    50.60K0.47%
  • Fidelity Series Total Market Index
    12.08K0.11%

Stock Splits

  • Aug 10, 20261:35
  • Sep 6, 20241:8
  • Nov 2, 20231:10